VeriMomdisodium phenyl dibenzimidazole tetrasulfonate hamilelikte güvenli mi?
No harmonised reproductive classification (no H360/H361) was identified on ECHA and no SCCS or CIR reproductive safety opinion for this ingredient was found; peer‑reviewed reproductive/toxicology studies are lacking. Urinary excretion after topical application shows measurable systemic absorption in humans, so exposure (not hazard) is present. (ECHA substance page; PubMed urinary excretion study).
Pregnancy-safe products containing disodium phenyl dibenzimidazole tetrasulfonate
Related ingredients
Frequently asked questions
- disodium phenyl dibenzimidazole tetrasulfonate hamilelikte güvenli mi?
- No harmonised reproductive classification (no H360/H361) was identified on ECHA and no SCCS or CIR reproductive safety opinion for this ingredient was found; peer‑reviewed reproductive/toxicology studies are lacking. Urinary excretion after topical application shows measurable systemic absorption in humans, so exposure (not hazard) is present. (ECHA substance page; PubMed urinary excretion study).
- disodium phenyl dibenzimidazole tetrasulfonate emzirirken güvenli mi?
- No data were found on lactational transfer or breastmilk levels and no reproductive/human developmental toxicity signals were identified in authoritative regulatory sources. Given measurable dermal absorption (urinary excretion), low but measurable maternal systemic exposure is plausible and could theoretically lead to trace exposure via breastmilk, so exposure is scored as low/measurable. No data justify raising hazard or mechanism scores.
- disodium phenyl dibenzimidazole tetrasulfonate bebek cildi için güvenli mi?
- No infant‑specific toxicity or developmental skin studies were found and no harmonised reproductive classification exists. Measurable systemic absorption after topical use in adults was reported (urinary excretion), and per your rule the exposure score for baby skin is increased by +1 relative to adult because of immature barrier and higher surface‑area:weight, giving moderate exposure for 0–3 y olds. No mechanistic or reproductive hazard evidence was found to change h or m.
- VeriMom disodium phenyl dibenzimidazole tetrasulfonate nasıl puanlıyor?
- VeriMom disodium phenyl dibenzimidazole tetrasulfonate'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 93/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte disodium phenyl dibenzimidazole tetrasulfonate yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.